Citation Impact
Citing Papers
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
1989
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
2000
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
p185HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor
1989
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
1992 StandoutNature
Cell Death Mechanisms and the Immune System
1991
Inflammation and metabolic disorders
2006 StandoutNature
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
1995
Oncogenic kinase signalling
2001 StandoutNature
Protein-tyrosine Phosphatase Inhibitors Block Tumor Necrosis Factor-dependent Activation of the Nuclear Transcription Factor NF-kB
1995
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
1988
Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome.
1989
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
1996
Death by TNF: a road to inflammation
2022
The salt-wasting phenotype of EAST syndrome, a disease with multifaceted symptoms linked to the KCNJ10 K+ channel
2011
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Two TNF receptors
1992
Tumor necrosis factor expression in human epithelial tumor cell lines.
1988
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Assays for tumour necrosis factor and related cytokines
1989
Interferon‐γ and interleukin‐1β inhibit adipoconversion in cultured rodent preadipocytes
1992
Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
1988
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Inflammatory Mediators, Cytokines, and Adhesion Molecules in Pulmonary Inflammation and Injury
1996
Characterization of differentiation factor/leukaemia inhibitory factor effect of lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes
1994
Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor .alpha.
1989
Immunity, Inflammation, and Cancer
2010 Standout
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
1989
Molecular cloning and expression of a receptor for human tumor necrosis factor
1990
HIV as the cause of AIDS
1996 StandoutNobel
Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors
1991 StandoutNatureNobel
Atherosclerosis — An Inflammatory Disease
1999 Standout
The Fas Death Factor
1995 StandoutScience
The metabolic effects of tumor necrosis factor and other cytokines
1991
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
1988
Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.
1992
Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
1996
Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase
1999
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Tumour necrosis factor and cancer
2009
Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
1991
Tumour necrosis factor in man: Clinical and biological observations
1987
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Molecular control of tissue‐specific expression at the mouse TNF locus
1989
Interleukin-6 stimulates hepatic triglyceride secretion in rats.
1995
Renal localization and function of the tight junction protein, claudin-19
2007
Cancer-related inflammation
2008 StandoutNature
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution
1992 StandoutNobel
Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
1987
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
2002
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
1991
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
1990
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
1993 StandoutNature
The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution
1989
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.
1989
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
1992
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Magnesium in Man: Implications for Health and Disease
2014 Standout
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.
1992 StandoutNobel
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1.
1995
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine.
1984
Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.
1989
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.
1987
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue.
1988
Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
1986
Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
1989
Cachectin alters anterior pituitary hormone release by a direct action in vitro.
1989 StandoutNobel
Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
1985 StandoutScienceNobel
Synergistic Activation of NF-κB by Tumor Necrosis Factor Alpha and Gamma Interferon via Enhanced IκBα Degradation and De Novo IκBβ Degradation
1997
Identification of a Protein with Homology to hsp90 That Binds the Type 1 Tumor Necrosis Factor Receptor
1995
Death Receptors: Signaling and Modulation
1998 StandoutScience
Adipsin and an endogenous pathway of complement from adipose cells.
1992
Understanding Adipocyte Differentiation
1998 Standout
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
1989
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
1991
Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.
1994 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
1990 StandoutScience
Pathogenesis of human immunodeficiency virus infection
1993
Adipsin and Complement Factor D Activity: An Immune-Related Defect in Obesity
1989 Science
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition
2004
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Glycosphingolipid Binding Specificities of Rotavirus: Identification of a Sialic Acid-Binding Epitope
2001
Ultrastructural localization of Na-K-2Cl cotransporter in thick ascending limb and macula densa of rat kidney
1998
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Seppuku and Autoimmunity
1992 StandoutScienceNobel
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Chimeric tumor necrosis factor receptors with constitutive signaling activity.
1995 StandoutNobel
Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system.
1994
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
1994
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
1986 Nature
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
1988
Inactivation of CMP- N -acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution
2002 StandoutNobel
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes.
1994
Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
1992
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
1999
Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes
1988
A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
1985 StandoutScienceNobel
Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.
1986
Uncompensated polyuria in a mouse model of Bartter's syndrome
2000 StandoutNobel
Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat.
1989
Biological Role and Potential Therapeutic Targeting of the Chemokine Receptor CXCR4 in Undifferentiated Thyroid Cancer
2007
A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins
1990 Science
A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
1989
Unraveling Function in the TNF Ligand and Receptor Families
1994 StandoutScienceNobel
Works of Thomas E. Eessalu being referenced
The effects of human recombinant tumor necrosis factor on glioma‐derived cell lines: Cellular proliferation, cytotoxicity, morphological and radioreceptor studies
1988
Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes.
1989
Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha
1987
Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
1987
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
1985 Nature
Localization of the ROMK protein on apical membranes of rat kidney nephron segments
1997
Activation of estradiol—receptor complex by ATP in vitro
1980
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
1986
Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.
1988
Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells.
1988
Purification and characterization of interleukin 1 receptor level antagonist proteins from THP-1 cells.
1990
Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response.
1993
Akt Activation, but not Extracellular Signal–Regulated Kinase Activation, Is Required for SDF-1α/CXCR4–Mediated Migration of Epitheloid Carcinoma Cells
2005